Aarti Pharmalabs Ltd.

The Revenue for the quarter ended  September 2024 of Rs. 3772.94 millions grew by 5.94 % from Rs. 3561.43 millions.The Company has registered profit of Rs. 478.37  millions for the quarter ended September 2024, a growth of 14.43%  over Rs. 418.06 millions millions achieved in the corresponding quarter of last year.OP of the company witnessed a marginal growth to 877.20 millions from 737.98 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202409	202309	% Var	202409	202309	% Var	202403	202303	% Var
Sales	3772.94	3561.43	5.94	7707.80	7142.87	7.91	15021.30	15112.50	-0.60
Other Income	29.47	0.00	0.00	50.60	48.59	4.14	110.10	12.80	760.16
PBIDT	877.20	737.98	18.87	1734.88	1554.01	11.64	3571.60	3096.20	15.35
Interest	53.93	38.16	41.33	96.42	78.50	22.83	166.30	204.90	-18.84
PBDT	823.27	699.82	17.64	1638.46	1475.51	11.04	3405.30	2891.30	17.78
Depreciation	188.93	163.16	15.79	371.86	317.53	17.11	660.10	557.70	18.36
PBT	634.34	536.66	18.20	1266.60	1157.98	9.38	2745.20	2333.60	17.64
TAX	155.97	118.60	31.51	316.79	263.60	20.18	738.70	616.30	19.86
Deferred Tax	28.03	15.00	86.87	73.18	50.00	46.36	278.10	95.00	192.74
PAT	478.37	418.06	14.43	949.81	894.38	6.20	2006.50	1717.30	16.84
Equity	453.13	453.13	0.00	453.13	453.13	0.00	453.10	453.10	0.00
PBIDTM(%)	23.25	20.72	12.20	22.51	21.76	3.46	23.78	20.49	16.05